Pharmanutra Future Growth
Future criteria checks 3/6
Pharmanutra is forecast to grow earnings and revenue by 18.5% and 13.1% per annum respectively. EPS is expected to grow by 1.8% per annum. Return on equity is forecast to be 29.3% in 3 years.
Key information
18.5%
Earnings growth rate
1.8%
EPS growth rate
| Personal Products earnings growth | 8.0% |
| Revenue growth rate | 13.1% |
| Future return on equity | 29.3% |
| Analyst coverage | Low |
| Last updated | 12 Nov 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 151 | 25 | 24 | 28 | 2 |
| 12/31/2025 | 133 | 22 | 21 | 24 | 2 |
| 12/31/2024 | 117 | 19 | 17 | 20 | 2 |
| 9/30/2024 | 114 | 16 | 19 | 23 | N/A |
| 6/30/2024 | 108 | 14 | 15 | 20 | N/A |
| 3/31/2024 | 101 | 11 | 2 | 12 | N/A |
| 12/31/2023 | 101 | 13 | -1 | 12 | N/A |
| 9/30/2023 | 95 | 12 | -5 | 12 | N/A |
| 6/30/2023 | 93 | 14 | -19 | 12 | N/A |
| 3/31/2023 | 88 | 16 | -15 | 14 | N/A |
| 12/31/2022 | 83 | 15 | -9 | 17 | N/A |
| 9/30/2022 | 79 | 16 | -5 | 19 | N/A |
| 6/30/2022 | 76 | 15 | 10 | 19 | N/A |
| 3/31/2022 | 73 | 15 | 14 | 20 | N/A |
| 12/31/2021 | 68 | 14 | 15 | 20 | N/A |
| 9/30/2021 | 65 | 14 | 13 | 16 | N/A |
| 6/30/2021 | 60 | 11 | 12 | 15 | N/A |
| 3/31/2021 | 57 | 14 | 13 | 15 | N/A |
| 12/31/2020 | 57 | 14 | 10 | 12 | N/A |
| 9/30/2020 | 58 | 14 | 11 | 11 | N/A |
| 6/30/2020 | 58 | 14 | 7 | 11 | N/A |
| 3/31/2020 | 55 | 9 | 4 | 9 | N/A |
| 12/31/2019 | 54 | 8 | 7 | 12 | N/A |
| 9/30/2019 | 49 | 8 | 3 | 8 | N/A |
| 6/30/2019 | 50 | 9 | 7 | 9 | N/A |
| 3/31/2019 | 48 | 9 | 6 | 8 | N/A |
| 12/31/2018 | 47 | 9 | 6 | 6 | N/A |
| 9/30/2018 | 44 | 8 | 5 | 6 | N/A |
| 6/30/2018 | 41 | 7 | N/A | 6 | N/A |
| 3/31/2018 | 40 | 6 | N/A | 6 | N/A |
| 12/31/2017 | 38 | 6 | N/A | 6 | N/A |
| 9/30/2017 | 37 | 5 | N/A | N/A | N/A |
| 6/30/2017 | 35 | 5 | N/A | N/A | N/A |
| 3/31/2017 | 34 | 4 | N/A | N/A | N/A |
| 12/31/2016 | 33 | 4 | N/A | 6 | N/A |
| 12/31/2015 | 26 | 3 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 761's forecast earnings growth (18.5% per year) is above the savings rate (1%).
Earnings vs Market: 761's earnings (18.5% per year) are forecast to grow slower than the German market (21.1% per year).
High Growth Earnings: 761's earnings are forecast to grow, but not significantly.
Revenue vs Market: 761's revenue (13.1% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: 761's revenue (13.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 761's Return on Equity is forecast to be high in 3 years time (29.3%)